Category Archives: Biotechnology

In our fast-moving world, biotech is at the forefront of developments but, by its very nature, it can provoke ethical and moral concerns. The European Patent Office (EPO) has faced opposition in the past, for instance, over patents relating to processes for re-engineering genes, for use in medical research into cancer treatment. These processes could apply to various animals, including great apes and that became a magnet for criticism from animal rights campaigners. The number of patent filings for biotechnology increased by 0.3 percent in 2016, to 5,744 making it the tenth largest sector in its field. Youris.com spoke to Benoit Battistelli, President of the EPO, about the role of patent protection and how it can aid biotechnology innovation and the wider bioeconomy despite the obstacles faced by some. Benoit Battistelli -Courtesy of EPO How much of a focus is the bioeconomy for patents and what are some of the key developments? Biosciences play an important role in patent applications at the EPO, given the growing convergence of technologies, which is widely responsible for technical progress in a wide number of sectors. Such inventions are mainly found in industrial biotechnology, for instance, in the development of novel products such as … Continue reading →

Barron's Earnings Preview: Biotechnology Looks Healthy Barron's The iShares Nasdaq Biotechnology (IBB) has climbed 0.34%. Meanwhile the SPDR S&P Biotech ETF (XBI) has declined 0.21%. IBB could be benefiting from having a wider swath of companies, in addition to the fact that the average market cap of its index ... and more » Read more here: Earnings Preview: Biotechnology Looks Healthy - Barron's … Continue reading →

[The following is the first part of anInformation Technology and Innovation Foundation report.] New techniques for improving plants and animals promise to reshape virtually every aspect of the relationship between humans and our environment for the better. Safer and more sustainable crops have already made enormous contributions to the economy and the environment, and genetically improved livestock and companion animals are close behind. Discovery of more precise, predictable, and easily used techniques derived directly from nature is dramatically accelerating this progress. But fears of the new have led to calls in many nations for precautionary regulation, which risks stifling agricultural innovation without any showing of need or benefit. There is a better way. This report discusses proposals for updating policies and regulations for agricultural biotechnology products in the United States to ensure they safeguard This report discusses proposals for updating policies and regulations for agricultural biotechnology products in the United States to ensure they safeguard public and environmental health and animal welfare without discouraging needed innovations. An authoritative review of 10 years worth of academic literature has found that the scientific research conducted so far has not detected any significant hazards directly connected with the use of [genetically engineered] crops. … Continue reading →

Technical Roundup On Two Stocks - Puma Biotechnology, Inc. (PBYI), Diamond Offshore Drilling, Inc. (DO) Post Analyst Puma Biotechnology, Inc. has a consensus outperform rating from 7 Wall Street analysts, and the number of shares currently sold short amount to at least 27.36% of shares outstanding. The stock sank -19.31% last month and is up 17.75 this year. Wall ... and more » Read this article: Technical Roundup On Two Stocks - Puma Biotechnology, Inc. (PBYI), Diamond Offshore Drilling, Inc. (DO) - Post Analyst … Continue reading →

President Macky Sall of Senegal has thrown his weight behind the adoption of agricultural biotechnology in the country. . President Sall made it clear that he supported the implementation of biotechnology in Senegal provided necessary measures to minimise risks were taken. Macky Sall I must say very clearly that I am for the use of GMOs based on the precautions taken and based on a dynamic regulation, otherwise we would be against progress. We must decide and step forward. We need to move forward because we have food security imperatives. It is undeniable that GMOs can help meet current challenges, such as food insecurity, public health issues, natural resource conservation and climate change, he stressed. We need serious thought to develop a strategy to maximise the use of GMOs, while mitigating the risks associated with them. That is why it is necessary to strengthen the National Biosafety Authority and to have an appropriate legal system combined with an efficient information system based on objective scientific values to assess the cost/benefit/risks ratio, he further stressed. The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion, and analysis. Read full, original post:GMOs: Senegal supports adoption of agric biotech … Continue reading →

Puma Biotechnology, Inc. (PBYI) recently sold by insider CHARNAS ROBERT Post Analyst Puma Biotechnology, Inc. (NASDAQ:PBYI) reached 85.92% versus a 1-year low price of $19.74. The stock was last seen 2.95% higher, reaching at $36.7 on Apr. 10, 2017. At recent session, the prices were hovering between $35.24 and $37.8. This company ... Brokerages Anticipate Puma Biotechnology Inc (PBYI) Will Post Quarterly Sales of $0.00The Cerbat Gem Puma Biotechnology Inc (PBYI) Expected to Announce Earnings of -$1.86 Per ShareBBNS Analyst's Indicator Review for Puma Biotechnology, Inc. (PBYI ...The USA Commerce Midway Monitor -Chaffey Breeze all 12 news articles » More here: Puma Biotechnology, Inc. (PBYI) recently sold by insider CHARNAS ROBERT - Post Analyst … Continue reading →

Lets take a quick look at where covering equity analysts see iShares Nasdaq Biotechnology Index Fund (NASDAQ:IBB) going in the future. Analysts polled by Thomson Reuters have a current consensus target on company stock of $N/A. It is important to mention that target price projections can be very different between analysts. Covering analysts use their acquired knowledge and expertise to help create their best calculation of where they think the stock may be moving in the future. Analysts and investors may use different metrics in order to calculate a price target projection. A very common metric used is the price to earnins ratio of a company. This calculation comes from dividing the current share price by the projected earnings per share. At the time of writing, iShares Nasdaq Biotechnology Index Fund (NASDAQ:IBB) has a P/E Ratio of N/A. Investors may also examine a companys PEG or price to earnings growth ratio. The PEG ratio represents the ratio of the price to earnings to the anticipated future growth rate of the company. A company with a PEG Ratio below one may be seen as undervalued while a PEG Ratio above one may signal that the company is overvalued. A PEG Ratio … Continue reading →

Post Analyst -$1.86 Earnings Per Share Expected for Puma Biotechnology Inc (PBYI) This Quarter The Cerbat Gem Puma Biotechnology logo Equities research analysts expect Puma Biotechnology Inc (NYSE:PBYI) to post earnings per share of ($1.86) for the current quarter, Zacks Investment Research reports. Zero analysts have made estimates for Puma Biotechnology's ... Consensus Analysts Roundup on Puma Biotechnology, Inc. (NYSE:PBYI) Ocular Therapeutix, Inc. (NASDAQ:OCUL)Davidson Register Puma Biotechnology Inc (PBYI) Receives $70.50 Average PT from ...Chaffey Breeze Short Term Technical Outlook: Puma Biotechnology, Inc. (PBYI), Adeptus Health Inc. (ADPT)Post Analyst TCT -Street Updates all 13 news articles » View original post here: -$1.86 Earnings Per Share Expected for Puma Biotechnology Inc (PBYI) This Quarter - The Cerbat Gem … Continue reading →

Barron's (blog) Earnings Preview: Biotechnology Looks Healthy Barron's (blog) The iShares Nasdaq Biotechnology (IBB) has climbed 0.34%. Meanwhile the SPDR S&P Biotech ETF (XBI) has declined 0.21%. IBB could be benefiting from having a wider swath of companies, in addition to the fact that the average market cap of its index ... and more » Excerpt from: Earnings Preview: Biotechnology Looks Healthy - Barron's (blog) … Continue reading →

Post Analyst Analyst Views On Top Movers In Recent Trade: Puma Biotechnology ... Post Analyst Puma Biotechnology, Inc. (NASDAQ:PBYI) last session's volume of 0.71 million shares was lower than its average volume of 0.96 million shares. The stock, after ... The Puma Biotechnology Inc (PBYI) Shares Bought by Highbridge Capital Management LLCPetro Global News 24 Puma Biotechnology Inc (PBYI) Expected to Announce Earnings of ...Sports Perspectives Puma Biotechnology Inc (PBYI) Receives Consensus ...Community Financial News MilTech all 9 news articles » Originally posted here: Analyst Views On Top Movers In Recent Trade: Puma Biotechnology ... - Post Analyst … Continue reading →